oncology
BMSโ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer
February 5, 2026Research and Development BMS, Scottish Medicines Consortium, colorectal cancer, oncology
Bristol Myers Squibb (BMS) has announced that its Opdivo (nivolumab) has been accepted, in combination with Yervoy (ipilimumab), by the …
Astellas Pharmaโs Vyloy accepted by Scottish Medicines Consortium for gastric cancer
February 4, 2026Research and Development Astellas Pharma, Scottish Medicines Consortium, Vyloy, gastric cancer, oncology
Astellas Pharma, a pharmaceutical company creating medicines to address unmet medical needs, has announced that Vyloy (zolbetuximab), in combination with …
Rethinking oncology trial endpoints with generalised pairwise comparisons
November 4, 2025Research and Development EMA, FDA, Oncology, One2Treat, clinical trials, generalised pairwise comparisons, net treatment benefit, oncology
For decades, oncology trials have been anchored to a familiar set of endpoints. Overall survival (OS) and progression-free survival (PFS) …
Pharma&โs ovarian cancer therapy approved for use by NHS Scotland
October 29, 2025Pharma&, Rubraca, Scottish Medicines Consortium, nhs scotland, oncology, ovarian cancer
Pharma& has announced that its treatment for ovarian cancer, Rubraca (rucaparib), has been accepted by the Scottish Medicines Consortium (SMC) …
Bio-Rad signs exclusive European distribution deal with Gencurix for oncology testing kits
October 6, 2025Research and Development Bio-Rad, Diagnostics and Testing, Gencurix, oncology
The agreement expands access to oncology testing kits across Europe
Micrima announces upcoming launch of new UK breast cancer assessment
October 3, 2025Research and Development Micrima, breast cancer, oncology
Breast cancer remains one of the leading health threats to women over 35 in the UK Micrima, a healthcare technology …
Combination treatments: Takedaโs Implementation Framework and the broader landscape
September 23, 2025Research and Development HIV/AIDS, Hepatology, NHS, NICE, Oncology, Takeda, combination therapy, oncology
Pharmafile talks to Emma Roffe, Oncology Country Head (UK & Ireland) about the combination treatment landscape and the impact of …
BioMed X and Servier launch Europeโs first XSeed Labs to advance AI-powered antibody design
July 11, 2025Research and Development BioLabs, BioMed X, Cancer, Oncology, Servier, XSeed Labs, antibody therapy, oncology
BioMed X and Servier have announced the launch of Europeโs first XSeed Labs research project, located at the Spartners incubator …
ANGLEโs Parsortix system used in new cancer biology research
June 10, 2025Medical Communications, Research and Development Angle, Oncology, Parsortix system, R&D, biotech, oncology, scientific journals
ANGLE has announced three new peer-reviewed publications demonstrating the use of its Parsortix circulating tumour cell (CTC) harvesting system in …
BioNTech and Bristol Myers Squibb collaborate on bispecific antibody for solid tumours
June 6, 2025Research and Development BioNTech, Oncology, bispecific antibody treatment, bristol myers squibb, oncology, partnership
BioNTech and Bristol Myers Squibb (BMS) have entered a partnership to collaboratively develop and commercialise BNT327, BioNTechโs bispecific antibody, to …
Ryvu Therapeutics appoints Justyna ลปรณลtek to management board
May 29, 2025Medical Communications, Research and Development Oncology, Ryvu Therapeutics, chief people officer, human resources, management board, oncology
Ryvu Therapeutics has promoted Justyna ลปรณลtek, chief people officer, to its management board. The appointment reflects the companyโs focus on …
The Royal Marsden launches AI radiology platform to revolutionise cancer care
May 27, 2025Analytical & Laboratory Services, Market & Product Development, Medical Education, Research and Development AI, CARPL.ai., Institute of Cancer Research, NTT DATA, National Institute for Health and Care Research, Oncology, The Royal Marsden, oncology, radiology
The Royal Marsden, a world-leading cancer research centre, has launched a large-scale, AI-powered radiology platform designed to accelerate cancer detection …
Novartis releases new data across oncology and haematology pipelines
May 21, 2025Research and Development ASCO, EHA, Haematology, Novartis, Oncology, oncology
Novartis has announced it will present new data at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting taking …
Landmark BioVentures launches spin-off biotech to tackle fibrotic, neoplastic and neovascularised conditions
May 20, 2025Research and Development Aix-Marseille University, Cardiology, Corporate, Landmark BioVentures, Massalia Therapeutics, Oncology, cardiovascular research, oncology
Landmark BioVentures and researchers at Aix-Marseille University in Marseille, France, have launched Massalia Therapeutics. Marking Landmarkโs seventh company, the spin-off …
Infinitopes launches first-in-human trial of vaccine targeting oesophageal cancer
April 9, 2025Research and Development Infinitopes, Oncology, biotech, oesophageal cancer, oncology
The cancer biotech company Infinitopes has gained approval by the UK Medicines and Healthcare products Regulatory Agency (MHRA) to evaluate …
